Literature DB >> 31569018

Selenoxide elimination manipulate the oxidative stress to improve the antitumor efficacy.

Chenxing Sun1, Lu Wang1, Banruo Xianyu1, Tianyu Li1, Shiqian Gao2, Huaping Xu3.   

Abstract

Selenoxide elimination reaction has been widely used in the field of organic synthesis. However, few studies have been conducted to apply this reaction in biodegradable nanomedicine. In this work, the selenoxide elimination reaction was used for cancer treatment via producing excess cellular reactive oxygen species (ROS) for the first time. The β-seleno diesters and porphyrin derivates containing nanoparticle could be responsive to the intracellular ROS and produce acrylates through the elimination reaction. The acrylates would further deplete intracellular GSH in tumor cells and finally improved the anticancer activity in the mice tumor model. Different from traditional ROS-responsive nanomedicine, the elimination product of this reaction could regenerate cytotoxic ROS and specifically disturb the redox balance of tumor cells. This work would provide attractive avenues for the development of therapeutic strategies against cancer via synthesis of well-designed biodegradable polymers.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Oxidation therapy; ROS; Selenoxide elimination; β-Seleno diesters

Mesh:

Substances:

Year:  2019        PMID: 31569018     DOI: 10.1016/j.biomaterials.2019.119514

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  6 in total

1.  Thioanisole ester based logic gate cascade to control ROS-triggered micellar degradation.

Authors:  Irene Piergentili; Pepijn R Bouwmans; Luuk Reinalda; Reece W Lewis; Benjamin Klemm; Huanhuan Liu; Robin M de Kruijff; Antonia G Denkova; Rienk Eelkema
Journal:  Polym Chem       Date:  2022-03-30       Impact factor: 5.364

2.  Yolk-shell nanovesicles endow glutathione-responsive concurrent drug release and T1 MRI activation for cancer theranostics.

Authors:  Dahai Liu; Zijian Zhou; Xinyu Wang; Hongzhang Deng; Lin Sun; Haixin Lin; Fei Kang; Yong Zhang; Zhantong Wang; Weijing Yang; Lang Rao; Kuikun Yang; Guocan Yu; Jianshi Du; Zheyu Shen; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2020-03-16       Impact factor: 12.479

3.  ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.

Authors:  Hanxi Yi; Wangxing Lu; Fan Liu; Guoqing Zhang; Feifan Xie; Wenjie Liu; Lei Wang; Wenhu Zhou; Zeneng Cheng
Journal:  J Nanobiotechnology       Date:  2021-05-11       Impact factor: 10.435

4.  Selenoxide Elimination Triggers Enamine Hydrolysis to Primary and Secondary Amines: A Combined Experimental and Theoretical Investigation.

Authors:  Giovanni Ribaudo; Marco Bortoli; Erika Oselladore; Alberto Ongaro; Alessandra Gianoncelli; Giuseppe Zagotto; Laura Orian
Journal:  Molecules       Date:  2021-05-08       Impact factor: 4.411

5.  Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassemblies.

Authors:  Lingxiao Li; Shiyi Zuo; Fudan Dong; Tian Liu; Yanlin Gao; Yinxian Yang; Xin Wang; Jin Sun; Bingjun Sun; Zhonggui He
Journal:  Asian J Pharm Sci       Date:  2021-02-25       Impact factor: 6.598

6.  Antioxidant stress and anticancer activity of peptide‑chelated selenium in vitro.

Authors:  Xian Li; Xianjue Wang; Gang Liu; Yanan Xu; Xinlin Wu; Ru Yi; Feng Jin; Chula Sa; Xiulan Su
Journal:  Int J Mol Med       Date:  2021-06-24       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.